Pediatric CKD and cardiovascular disease

Area of Science:

• Pediatric Nephrology
• Cardiovascular Research
• Atherosclerosis Studies

Background:

• Children and adolescents with chronic kidney disease (CKD) exhibit elevated risks for cardiovascular morbidity and mortality.
• Early indicators of atherosclerosis, such as endothelial dysfunction, are prevalent in pediatric CKD patients.
• Vascular abnormalities including increased carotid artery intima media thickness and coronary artery calcification are common in this population.

Purpose of the Study:

• To comprehensively review the risk factors contributing to early atherosclerosis in pediatric CKD.
• To highlight the significance of endothelial dysfunction as an early marker of cardiovascular risk in children with CKD.
• To emphasize the importance of managing modifiable risk factors to prevent cardiovascular complications.

Main Methods:

• Literature review of studies focusing on atherosclerosis and cardiovascular risk factors in children with CKD.
• Analysis of evidence linking CKD to endothelial dysfunction and structural vascular changes.
• Synthesis of information on hypertension, dyslipidemia, renal bone disease, hyperhomocysteinemia, and uremia-related factors.

Main Results:

• Endothelial dysfunction is an early precursor to atherosclerosis in pediatric CKD, evidenced by specific vascular changes.
• Numerous modifiable risk factors, including hypertension, dyslipidemia, and hyperhomocysteinemia, are associated with CKD in children.
• These risk factors are frequently observed and contribute significantly to the high cardiovascular risk.

Conclusions:

• Optimal clinical management of modifiable risk factors can delay or prevent cardiovascular disease in children with CKD.
• Slowing the progression of renal disease is a key strategy to reduce the risk of premature cardiac disease and mortality.
• Early identification and intervention for atherosclerosis risk factors are essential in pediatric CKD care.